Stockreport

Havas Health and BrightInsight Forge Exclusive Alliance to Tackle Pharma's $500B+ Patient Problem [Yahoo! Finance]

VIVENDI SE UNSP/ADR  (VIVHY) 
NASDAQ:AMEX Investor Relations: vivendi.com/en/investment-analysts
PDF biopharma to deliver digital persistence and adherence solutions. This collaboration designates Havas Health as BrightInsight's single global agency partner, creating a [Read more]